3'-deoxycytidine has been researched along with cytarabine in 1 studies
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
*Cytarabine: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) [MeSH]
| Studies (3'-deoxycytidine) | Trials (3'-deoxycytidine) | Recent Studies (post-2010) (3'-deoxycytidine) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | 3'-deoxycytidine (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, GI; Brankovan, V; Cheng, YC; Ghazzouli, I; Giziewicz, J; Lin, TS; Liu, MC; Prusoff, WH; Shen, ZY; Yang, JH | 1 |
1 other study(ies) available for 3'-deoxycytidine and cytarabine
| Article | Year |
|---|---|
Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Topics: Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry; Cytarabine; Leukemia L1210; Leukemia P388; Mice; Pyrimidine Nucleosides; Sarcoma 180; Structure-Activity Relationship; X-Ray Diffraction | 1991 |